© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
May 20, 2021
Melanoma forms when pigment-producing cells called melanocytes mutate and multiply uncontrollably.
March 30, 2021
In England, incidence rates of the skin cancer cutaneous malignant melanoma were found to have increased by more than 550% among males and 250% among females since the early 1980s.
January 26, 2021
The FDA has granted toripalimab a fast track designation for use in the frontline treatment of patients with mucosal melanoma.
January 11, 2021
Pvsripo is a novel immunotherapy that activates patients’ innate and adaptive immune system to enable anti-tumor response and establish immunologic memory to prevent the recurrence of cancer.
December 16, 2020
Counseling patients on possible adverse effects that impact skin health can help patients prepare for serious or cosmetic impacts.
November 23, 2020
To analyze digital images of metastatic tumors of melanoma, the researchers used computer algorithms, or deep convolutional neural networks (DCCN), to identify patterns associated with treatment response.
November 03, 2020
The researchers isolated human primary keratinocytes from the skin of patients with non-melanoma skin cancers.
September 23, 2020
More than half of high-risk patients with resected, stage III BRAF V600-mutated melanoma who were treated with dabrafenib and trametinib were alive and relapse-free at 5 years.
August 28, 2020
This activity is supported by an educational grant from Merck Sharp & Dohme Corp..
July 31, 2020
Officials with the FDA have approved atezolizumab plus cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive advanced melanoma.